An overview of the mutations of TP53, ATM, PIK3CA and EGFR in the primary lesions of 55 patients with PPC is provided in Fig. 1 (detailed information is provided in Supplemental Table S1). This evidence concerns the gene EGFR and primary peritoneal carcinoma.